Olema Pharmaceuticals, Inc. (OLMA)
29.16
+0.39
(+1.36%)
USD |
NASDAQ |
Jan 15, 16:00
29.43
+0.27
(+0.93%)
After-Hours: 20:00
Olema Pharmaceuticals SG&A Expense (TTM): 18.61M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| Cidara Therapeutics, Inc. | 28.09M |
| Cogent Biosciences, Inc. | 51.34M |
| Replimune Group, Inc. | 102.36M |
| Genprex, Inc. | 6.261M |